Learn how Endovan works to boost the body's ability to break down excess fibrin & painful adhesions in women with ovarian cysts.
When ovarian cysts are developed and do not dissolve normally the body's initial response is to trigger inflammation, the process by which the body sends white blood cells and other substances, including fibrin, to the affected area.
Fibrin is a fibrous protein involved in the clotting of blood and in protecting tissues identified by inflammation. When fibrin reaches the site of inflammation such as a ruptured cyst, it creates a barrier to prevent further spread of damaged or abnormal tissue. When excess fibrin is present, can form fibrous bands called adhesions.
Adhesions are internal scar tissue that can result from fibrin build up at the sites of cyst-induced inflammation. Adhesions are the primary cause of pain in sufferers of ovarian cysts and are difficult for the body to break down.
Plasmin, the enzyme we produce to break down fibrin accumulations, is sent to the affected site but it is not always powerful enough on its own to resolve the problem.
Endovan increases the fibrinolytic activity (fibrin-degrading) in the blood by encouraging increased plasmin production as well as by mimicking the function of plasmin.
With a more robust plasmin response, the body is better able to break down accumulated fibrin allowing the immune system to clean up the site and direct the debris to be processed as waste.